Company Neurokine Pharmaceuticals Inc Other OTC
Equities
CAC611561100
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 03 | BetterLife Pharma Inc. announced that it has received CAD 1.168 million in funding | CI |
Mar. 04 | BetterLife Pharma Inc. announced that it expects to receive CAD 0.1 million in funding | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 07-09-16 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 10-12-25 |
Chief Operating Officer | 67 | - | |
Wolfgang Renz
BRD | Director/Board Member | 54 | 15-02-04 |
David Melles
IRC | Investor Relations Contact | - | 21-09-28 |
Anthony Calandra
LAW | General Counsel | - | - |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 07-09-16 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 20-01-20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 15-02-04 |
Ralph Pullen
BRD | Director/Board Member | 79 | 20-05-04 |
Steven Sangha
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 113,825,305 | 88,051,525 ( 77.36 %) | 0 | 77.36 % |
Company contact information
BetterLife Pharma, Inc.
1275 West 6th Avenue Suite 300
V6H 1A6, Vancouver
+604 221 0595
http://www.abetterlifepharma.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- BETR.F Stock
- Stock
- Company Neurokine Pharmaceuticals Inc